Biomarkers and their potential value in diagnosis and treatment of psychosis disorders

Matcheri S. Keshavan MD, Stanley Cobb Professor and Academic Head of Psychiatry, Department of Psychiatry, Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Harvard Medical School

Psychiatric diagnosis is still symptom-based, and generally has limited value in treatment selection and outcome prediction.  In this presentation, the potential value of biomarkers will be discussed, especially as they pertain to the diagnosis and treatment early course psychotic disorders.

Register here: https://harvard.zoom.us/meeting/register/daqNfBF_RECGvmhEIOxylQ